speb/financial-data huggingface dataset:
UNI.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 15109166.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 54981965.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1966369.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 19773062.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 21739431.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 13166048.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 13166048.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 43646792.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 358139.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 358139.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 640467.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 850963.00
UNI.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 850963.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 850963.00
UNI.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 850963.00
UNI.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 19012229.00
UNI.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.05
UNI.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 879512.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 1249500.00
UNI.TO income_statement (quarterly, 2025-12-31) — EBIT: 1935428.00
UNI.TO income_statement (quarterly, 2025-12-31) — EBITDA: 2786391.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -33543.00
UNI.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 1286362.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -321558.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 32353869.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 780097.00
UNI.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 149024.00
UNI.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2759919.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 6384797.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 7567823.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 33697976.00
UNI.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 5813585.00
UNI.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 697455.00
UNI.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 697455.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -507239.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 40539498.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 50747077.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 932914.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 2622730.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Leases: 2842967.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 19327463.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 10872570.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 15416850.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 26289420.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -747233.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1543506.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: -97242.00
UNI.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -322.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 33903550.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income: 879512.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 879512.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 879834.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 879512.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 879512.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 879834.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 879834.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -697455.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 185681.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -747233.00
UNI.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -697455.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 16223546.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 932914.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 7989342.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 6622801.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 6622801.00
UNI.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2637367.00
UNI.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 773599.85
UNI.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 780097.00
UNI.TO income_statement (quarterly, 2025-12-31) — Operating Income: 1786404.00
UNI.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 20922751.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 19012229.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 445599.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 2303232.00
UNI.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 874595.00
UNI.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 149024.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1183026.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 697455.00
UNI.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 382393.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 21638416.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Payables: 8741313.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 8741313.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2655603.00
UNI.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 1237973.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 6486020.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 10500502.00
UNI.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 15109166.00
UNI.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 850963.00
UNI.TO income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 164897.00
UNI.TO income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 723892.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -747233.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -17193555.00
UNI.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1720427.00
UNI.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 33906.00
UNI.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2793825.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 19012229.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 932914.00
UNI.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 53060.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 15557165.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 7989342.00
UNI.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 43111.85
UNI.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 358139.00
UNI.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
UNI.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -9486.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 85396135.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 30974015.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 48028851.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 15459923.00
UNI.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 19136347.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 69936212.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 30414170.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 26289420.00
UNI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 149024.00
UNI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 149024.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 1699609.00
UNI.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 11335173.00
UNI.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 4340402.00
UNI.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 28650910.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7794266.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 15401836.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -18141334.00
UNI.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 19012229.00
UNI.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.11
UNI.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1286362.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 5050357.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 12397479.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 30447488.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 916167.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 916167.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 916167.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -2394600.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2089555.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 2934468.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -501671.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 741621.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -506194.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4894865.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2226641.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -305045.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 30447488.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 17743576.00
UNI.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 20473972.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 57080463.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2027043.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 18637093.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 20664136.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 12678988.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 12678988.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42386890.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 896744.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 896744.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 793642.00
UNI.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 793642.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 793642.00
UNI.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 793642.00
UNI.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 19012229.00
UNI.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.11
UNI.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2099700.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 1249500.00
UNI.TO income_statement (quarterly, 2026-03-31) — EBIT: 3782741.00
UNI.TO income_statement (quarterly, 2026-03-31) — EBITDA: 4576383.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -65150.00
UNI.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 916167.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2394600.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 30266309.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 2089555.00
UNI.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -53795.00
UNI.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2999340.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 6384797.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 7393772.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 33771107.00
UNI.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 8176938.00
UNI.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 677944.00
UNI.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 677944.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -494803.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 37600375.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 51678015.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 2622730.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Leases: 2846151.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 18180002.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 10370436.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 15297346.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 25667782.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -761440.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1544536.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: -24035.00
UNI.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -108353.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 33018272.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 53795.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income: 2099700.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2099700.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2208053.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2099700.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2099700.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2208053.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2208053.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -677944.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1864651.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -761440.00
UNI.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -677944.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -35146.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 15629773.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -1103211.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 10349804.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 5670205.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 5670205.00
UNI.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4630178.00
UNI.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 2137957.64
UNI.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2089555.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 53795.00
UNI.TO income_statement (quarterly, 2026-03-31) — Operating Income: 3836536.00
UNI.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 28650910.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 19012229.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 457091.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2357696.00
UNI.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 999136.00
UNI.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -53795.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1008975.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 677944.00
UNI.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 449127.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 21707333.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Payables: 9043766.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 9043766.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3162085.00
UNI.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 3104797.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 5712068.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 15401836.00
UNI.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 20473972.00
UNI.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 793642.00
UNI.TO income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 177177.00
UNI.TO income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 728339.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1864651.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -15061608.00
UNI.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1823027.00
UNI.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 98293.00
UNI.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3097633.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 19012229.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -1103211.00
UNI.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 54464.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 17743576.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 10349804.00
UNI.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -15537.36
UNI.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 896744.00
UNI.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
UNI.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -368446.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 85774213.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 33040922.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 46331918.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 17719541.00
UNI.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 24814374.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 68054672.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 28693750.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 25667782.00
UNI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -53795.00
UNI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -53795.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 1621998.00
UNI.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 14693573.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3788555000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 137902000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -31983000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Amortization: 1242000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 3990170000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 839101000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 252862000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 15912000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2847000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 2225943000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 324774000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 4986314000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Interest Income: 64777000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 64777000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 559990000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 399617000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 9123285000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 46921000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 399617000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 1624743000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 221149000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Other Payable: 724575000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1579851000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 2533629000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 19195000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 19195000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Research And Development: 337564000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 49059000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 25060811000.00
UNICHEMLAB.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1206776000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1531550000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 10845000.00
UNICHEMLAB.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1021494000.00
UNICHEMLAB.NS income_statement (annual, 2022-03-31) — Write Off: 72389000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — +Operating Expense: 7848281000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — +Total Revenue: 13024201000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2906860000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 5886217000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4764564000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 137902000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -29519000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Amortization: 717000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 64766000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 70413510.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Basic EPS: -28.72
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1091963000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 5182680000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -443157000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 166526000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 140812000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1837522000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1852878000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -282545000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1500864000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 336658000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -250078000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Change In Payable: 1192611000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -1236146000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -293613000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 364227000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock: 140812000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 24353041000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1541420000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 6731739000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Assets: 15884651000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 51595000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt: 2337435000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2389030000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 6396008000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 120075000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Depreciation: 1134437000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1134437000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1134437000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1133720000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 70413510.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Diluted EPS: -28.72
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -2022276000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 14990000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 59000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — EBIT: -1601108000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — EBITDA: -466671000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1837522000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1609000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -812999000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 2261621000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -1294064000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -40329000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -12827000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 333221000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Goodwill: 15451000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 15451000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 5915736000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 18857142000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Gross Profit: 6292462000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Interest Expense: 162521000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 162521000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Interest Income: 5162000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 5162000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -162897000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 9427000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Inventory: 6252293000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 27326966000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 2028133000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1609000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 546055000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 114931000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 636490000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 751421000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -256632000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 11586987000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1136403000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 26560000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income: -2022276000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -2022276000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -2022276000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -2022276000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -2022276000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -1763629000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -2022276000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: -167963000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 2365103000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -333557000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -256632000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -167963000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 32962000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 14092578000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -379418000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -76925000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 24337590000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 10950000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 101127000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 419069000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1549365000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: -150156000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Normalized Income: -1800715500.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -850907000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Operating Income: -1555819000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 13024201000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 70405750.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 381332000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1859525000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 518943000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 120453000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 267900000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 167017000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 187165000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 10950000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 3449000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1649624000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 683219000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 12551158000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 103838000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 15356000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Other Special Charges: 372837000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Payables: 3609983000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1773318000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Pretax Income: -1763629000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 8918000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -443157000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 2908965000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 6731739000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1134437000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 8558000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 8558000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -256632000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Research And Development: 263939000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 16107000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 23975054000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 2365103000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 63739000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1295568000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1628789000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Special Income Charges: -407009000.00
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 10493000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 24353041000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 24337590000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -94954500.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 258647000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
UNICHEMLAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -122106000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 31930489000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 24989531000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 3140451000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 24353041000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 14580020000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 7577448000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 16045838000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1181440000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 10604000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 4914000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -316515000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -316515000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Work In Process: 813807000.00
UNICHEMLAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 9488643000.00
UNICHEMLAB.NS income_statement (annual, 2023-03-31) — Write Off: 34172000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 9097800000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 17376300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 3512600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 6423100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5801600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 137900000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -34300000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Amortization: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 59124000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Basic EPS: -13.32
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1837500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 5316100000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -225500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 283700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1547500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1560900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -2100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 1267300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 280200000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -794500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Change In Payable: -71500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -53900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -919900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -419100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 140800000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 24383000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1297700000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 8641300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 17433200000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 42100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1809300000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1851400000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 7376000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 1358500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 1231600000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1231600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1231600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1231600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 70405750.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: -13.32
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -937600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 12900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 0.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — EBIT: -628100000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 603500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1547500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -1063100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 3117700000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -85500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -712200000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -48600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 485400000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill: 15500000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 579100000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 6457400000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 19044200000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 8735000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 221500000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 221500000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 6700000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 6700000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -222300000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 5700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 7362600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 26574500000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 504000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 200000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 522700000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Liabilities Heldfor Sale Non Current: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 241600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 382200000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 623800000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -256600000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 11907700000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Net Debt: 644000000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -10000000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income: -937600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -937600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -937600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -937600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -937600000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -849600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -937600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: -219900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 652300000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -784800000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -256600000.00
UNICHEMLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -219900000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -18000000.00
UNICHEMLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 13242600000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -136000000.00
UNICHEMLAB.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -528200000.00